16th Annual Scientific Meeting - Heart Failure Society of America
16th Annual Scientific Meeting - Heart Failure Society of America
16th Annual Scientific Meeting - Heart Failure Society of America
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Sept. 11<br />
Tuesday<br />
AM<br />
SATELLITE SYMPOSIUM<br />
Tuesday, September 11<br />
7:00-8:00 AM<br />
Ballroom 6A<br />
SYMPOSIUM<br />
Tuesday, September 11<br />
7:00-8:15 AM<br />
<strong>Meeting</strong> Room 608/609<br />
Sept. 11<br />
Tuesday<br />
AM<br />
Tuesday<br />
Current and Emerging Therapies for <strong>Heart</strong><br />
<strong>Failure</strong> Patients with Mitral Regurgitation<br />
Moderator: JoAnn Lindenfeld, Denver, CO<br />
7:00 Welcome and Introduction: The Scope <strong>of</strong> the Problem<br />
JoAnn Lindenfeld, Denver, CO<br />
7:05 What Is the Evidence Base for Management <strong>of</strong> Mitral<br />
Regurgitation in Patients with <strong>Heart</strong> <strong>Failure</strong>?<br />
Robert O. Bonow, Chicago, IL<br />
7:20 High Risk Patients with Mitral Regurgitation: Severe LV<br />
Dysfunction and Comorbidities<br />
Steven F. Bolling, Ann Arbor, MI<br />
7:35 Percutaneous Therapies for Mitral Regurgitation:<br />
Current Data and Future Possibilities<br />
John D. Carroll, Denver, CO<br />
7:50 Panel Discussion<br />
Faculty<br />
Learning Objectives:<br />
1. Define specific types <strong>of</strong> mitral regurgitation<br />
2. Identify guidelines for the management <strong>of</strong> mitral<br />
regurgitation (MR) in patients with heart failure<br />
3. Identify ambiguous terms or areas not explicitly<br />
addressed by the guidelines<br />
4. Describe high risk patients with MR<br />
5. Follow appropriate treatment strategies for managing MR<br />
in patients with heart failure<br />
6. Discuss emerging therapeutic options in the treatment <strong>of</strong><br />
MR in patients with heart failure<br />
Supported by an educational grant from Abbott Vascular<br />
CLINICAL FUNDAMENTALS<br />
Strategies for National <strong>Heart</strong> <strong>Failure</strong> Care<br />
Moderators: Clyde W. Yancy, Chicago, IL<br />
7:00 The View from Washington<br />
Marvin A. Konstam, Boston, MA<br />
Barry H. Greenberg, La Jolla, CA<br />
7:15 How Many Patients, How Many Staff?<br />
Mariell L. Jessup, Philadelphia, PA<br />
7:23 Nurses, Nurse Practitioners, or Physician Assistants<br />
Suzanne J. Wingate, Gaithersburg, MD<br />
7:31 What Costs for Transplant and VADS are Sustainable?<br />
Joseph G. Rogers, Durham, NC<br />
7:39 The Michigan Model<br />
Keith D. Aaronson, Ann Arbor, MI<br />
7:47 The VA System as a Database Model<br />
Barry M. Massie, San Francisco, CA<br />
7:55 Panel Discussion<br />
Learning Objective: Identify factors affecting the transition<br />
from hospital to home for patients with heart failure and<br />
describe ways to manage them.<br />
Tuesday<br />
This symposium is not part <strong>of</strong> the scientific program as planned by<br />
the HFSA <strong>Scientific</strong> Program Committee.<br />
88 89
Change language